Form 4 for TROW T. Rowe Price
Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-22 · accession 0001562180-22-001714 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-23 | 2022-02-22 | TROW | Thomson Andrew Justin Mackenzie | VP | M - OptEx | $58.17 | +11.9K | 144.6K | +9% | +$691.7K |
| DM | 2022-02-23 | 2022-02-22 | TROW | Thomson Andrew Justin Mackenzie | VP | S - Sale+OE | $142.92 | -8,216 | 136.4K | -6% | -$1.17M |
| D | 2022-02-23 | 2022-02-22 | TROW | Thomson Andrew Justin Mackenzie | VP | M - OptEx | $0.00 | -11.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | M | A | 11,891 | $58.17 | 144,626 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-22 | S | D | 2,700 | $143.52 | 141,926 | D | — | — | (F1) The range of prices for this transaction were $143.19 to $143.75. Will provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-02-22 | S | D | 5,516 | $142.63 | 136,410 | D | — | — | (F2) The range of prices for this transaction were $142.17 to 143.15. Will provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Derivative | Stock Option | 2022-02-22 | M | D | 11,891 | $0.00 | 0 | D | $58.17 · — to 2022-02-23 | 11,891 Common Stock | (F3) 02/23/2012 Grant - The option vests 20% annually over a 5 year period beginning on 11/1/2013. |